BLEGD (Branded Legacy) EV-to-FCF: -0.08 (As of Jul. 01, 2026)


What is Branded Legacy EV-to-FCF?

Branded Legacy BLEGD EV-to-FCF is -0.08 as of Jul. 01, 2026.

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Branded Legacy's Enterprise Value is $0.02 Mil. Branded Legacy's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2021 was $-0.27 Mil. Therefore, Branded Legacy's EV-to-FCF for today is -0.08.

The historical rank and industry rank for Branded Legacy's EV-to-FCF or its related term are showing as below:

BLEGD's EV-to-FCF is not ranked *
in the Drug Manufacturers industry.
Industry Median: 20.52
* Ranked among companies with meaningful EV-to-FCF only.

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

As of today (2026-07-01), Branded Legacy's stock price is $0.0072. Branded Legacy's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2021 was $-4.021. Therefore, Branded Legacy's PE Ratio (TTM) for today is At Loss.


Branded Legacy  (OTCPK:BLEGD) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Branded Legacy's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=0.0072/-4.021
=At Loss

Branded Legacy's share price for today is $0.0072.
Branded Legacy's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2021 adds up the quarterly data reported by the company within the most recent 12 months, which was $-4.021.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Branded Legacy EV-to-FCF Related Terms


Branded Legacy EV-to-FCF Historical Data

* Premium members only.

The historical data trend for Branded Legacy's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Branded Legacy EV-to-FCF Chart

Branded Legacy Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
EV-to-FCF
Get a 7-Day Free Trial -753.47 -34.25 -4.58 -33.20 -58.52

Branded Legacy Quarterly Data
Dec15 Dec16 Dec17 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -33.20 -62.16 -21.01 -58.58 -58.52

BLEGD vs UPDC, RIBT, GDMK: EV-to-FCF Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Branded Legacy's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Branded Legacy EV-to-FCF vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Branded Legacy's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Branded Legacy's EV-to-FCF falls into.



Branded Legacy EV-to-FCF Calculation

Branded Legacy's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=0.023/-0.271
=-0.08

Branded Legacy's current Enterprise Value is $0.02 Mil.
Branded Legacy's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2021 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.27 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EV-to-FCF →
What does a EV-to-FCF of -0.08 mean?
Branded Legacy (BLEGD) has a EV-to-FCF of -0.08 as of Jul. 01, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Branded Legacy and its competitors.
Is Branded Legacy's EV-to-FCF too high?
Branded Legacy's current EV-to-FCF is -0.08.
How does Branded Legacy's EV-to-FCF compare to UPDC and RIBT?
Branded Legacy's EV-to-FCF of -0.08 can be compared against companies in the Drug Manufacturers industry. The industry median EV-to-FCF is 20.52. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Drug Manufacturers company?
The median EV-to-FCF among Drug Manufacturers companies is 20.52, based on 560 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Branded Legacy and its competitors. For the Drug Manufacturers industry, the median EV-to-FCF is 20.52 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Branded Legacy's current EV-to-FCF is -0.08. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Branded Legacy stock overvalued right now?
Branded Legacy (BLEGD) has a current EV-to-FCF of -0.08. The current EV-to-FCF is -0.08. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Branded Legacy (BLEGD), the current EV-to-FCF is -0.08 as of Jul. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Branded Legacy Business Description

Address 751 North Drive, Suite 9, Melbourne, FL, USA, 32934
Branded Legacy Inc provides high-level strategic advisory and operational transformation services focused on complex research, clinical development, and data-intensive organizations. Branded Legacy specializes in supporting large-scale international research consortia, platform clinical trials, and institutional/government data science initiatives. The core operations center on diagnosing operational inefficiencies, redesigning legacy systems, and implementing transparent, high-impact solutions that deliver measurable results.